Charles River Laboratories International Inc. disclosed compensation terms for incoming CFO Glenn Coleman, including an $800,000 annual base salary and a 2026 target bonus equal to 85% of base salary, prorated from his start date. He is slated to receive a $3.0 million 2026 equity award (60% performance share units and 40% restricted stock units), a one-time $1.875 million cash award paid in two installments at six and 12 months, and a one-time $3.5 million RSU grant vesting 25% per year over four years.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950103-26-002326), on February 18, 2026, and is solely responsible for the information contained therein.